Form 4: Greenwich LifeSciences CEO Buys Shares
Insider Transaction (Form 4)
Snehal Patel, CEO and CFO, a Director and 10% owner of Greenwich LifeSciences, Inc., purchased 3,600 shares of common stock on July 23, 2026.
Summary
- Open-market purchase: acquired 2,500 Common Stock at $13.14 ($32,850) on July 23, 2026; holds 5,606,602 after (Direct).
- Open-market purchase: acquired 1,100 Common Stock at $12.88 ($14,168) on July 24, 2026; holds 5,607,702 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $47,018, committing personal capital to the stock.
Insider Transactions
Snehal Patel — Director, Officer (CEO and CFO), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-23 | Open-market purchase | Common Stock | 2,500 | $13 | $32.9K | 5,606,602 |
| 2026-07-24 | Open-market purchase | Common Stock | 1,100 | $13 | $14.2K | 5,607,702 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-23 | Open-market purchase (2,500 shares) |
| 2026-07-24 | Open-market purchase (1,100 shares) |
Keywords
insider transaction, Form 4, GLSI, Greenwich LifeSciences, Inc., bullish, Snehal Patel
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.